Latest News
All Times Eastern
- Dow trims early gain as investors await more labor-market data
- As bitcoin’s price surges, crypto’s power in Washington withers
- Barron's Peaking Timing: Five Watches Ready for the Slopes
- U.S. oil prices dip below $70 a barrel, heading for a fifth straight loss
- Barron's Campbell Is the Best Performer in the S&P 500 After Earnings Beat
- ‘We can’t let Putin win’: Biden urges Congress to approve Ukraine aid
- Barron's Bank CEOs Warn Congress About Tougher Rules. Watch the Hearing Live.
- Barron's End of an Era at Raymond James: Longtime Leader Thomas James to Retire
- Barron's Plug Power Stock Gets Downgraded. There’s ‘Significant Risk’ to the Business Model.
- Disney’s ESPN wants to keep the NBA, but could the price be too high?
to be replaced
Illumina Inc.
ILMNUS
$
4.18
3.74%
Open
$
115.94
| Previous Close |
|---|
| $111.76 |
Volume: 1M
65 Day Avg: 2.44M
111.89
Day Range
117.79
89.00
52 Week Range
238.55
Partner Center
Your Watchlists
Recently Viewed Tickers
Overview
ILMN Overview
Key Data
- Open $113.33
- Day Range 111.89 - 117.79
- 52 Week Range 89.00 - 238.55
- Market Cap $17.75B
- Shares Outstanding 158.8M
- Public Float 158.12M
- Beta 1.10
- Rev. per Employee $388.26K
- P/E Ratio N/A
- EPS -$7.12
- Yield N/A
- Dividend N/A
- Ex-Dividend Date N/A
- Short Interest 5.42M 11/15/23
- % of Float Shorted 3.43%
- Average Volume 2.44M
Performance
| 5 Day |
|
| 1 Month |
|
| 3 Month |
|
| YTD |
|
| 1 Year |
|
Analyst Ratings
Number of Ratings 21
Full Ratings
Illumina Unusual Options Activity
on Benzinga.com
QQQ ETF Update, 11/28/2023
on TipRanks.com
Unveiling Illumina (ILMN)'s Value: Is It Really Priced Right? A Comprehensive Guide
Unveiling Illumina (ILMN)'s Value: Is It Really Priced Right? A Comprehensive Guide
on GuruFocus.com
QQQ ETF Update, 11/24/2023
on TipRanks.com
QQQ ETF Update, 11/22/2023
on TipRanks.com
ValueAct Capital Adjusts Portfolio, Major Reduction in Fiserv Inc by -8.04%
ValueAct Capital Adjusts Portfolio, Major Reduction in Fiserv Inc by -8.04%
on GuruFocus.com
Stifel Nicolaus Reaffirms Their Buy Rating on Illumina (ILMN)
on TipRanks.com
Unveiling Illumina (ILMN)'s Value: Is It Really Priced Right? A Comprehensive Guide
Unveiling Illumina (ILMN)'s Value: Is It Really Priced Right? A Comprehensive Guide
on GuruFocus.com
Company News for Nov 13, 2023
on Zacks.com
Illumina (ILMN): A Smart Investment or a Value Trap? An In-Depth Exploration
Illumina (ILMN): A Smart Investment or a Value Trap? An In-Depth Exploration
on GuruFocus.com
Why Illumina Inc Stock Is Falling
on Benzinga.com
12 Health Care Stocks Moving In Friday's Pre-Market Session
on Benzinga.com
Illumina Inc.
Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through the Core Illumina segment, which serves customers in the research, clinical and applied markets fields, and enables the adoption of a variety of genomic solutions. The firm's products include instruments, kits and reagents, selection tools, and software and analysis. Its services include sequencing and microarray services, proactive instrument monitoring, and instrument services, training, and consulting. The company was founded by David R. Walt, John R. Stuelpnagel, Anthony W. Czarnik, Lawrence A. Bock, and Mark S. Chee in April 1998 and is headquartered in San Diego, CA.
Competitors
| Name | Chg % | Market Cap |
|---|---|---|
| Laboratory Corp. of America Holdings | $18.85B | |
| Charles River Laboratories International Inc. | $10.29B | |
| Quest Diagnostics Inc. | $15.46B | |
| 10x Genomics Inc. | $5.47B | |
| Incyte Corp. | $12.32B | |
| Pacific Biosciences of California Inc. | $2.39B | |
| BGI Genomics Co. Ltd. | ¥21.22B | |
| Exelixis Inc. | $6.98B | |
| Invitae Corp. | $169.86M |